UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Black-Tie GayBINGO! is an event full of joy, affirmation and love,” said Mary Evelyn Torres, executive director of Action ...

UN Engagement: UNAIDS and WHO have engaged with the Tanzania AIDS Commission to assess the impact and discuss fundraising modalities to continue ongoing activities. The UN Country Team has also ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

The suspension of US foreign assistance could have a devastating effect on efforts to contain the spread of diseases in ...

For years, Namibia’s HIV response has been supported by US funding, particularly through the United States President's ...

She urged the public to disregard the misinformation and avoid unnecessary panic, adding that NACA'S priority is to sustain the progress made in controlling HIV/AIDS in NigeriaThe National Agency for ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...